Liver tumors: Pediatric population

Liver Transplantation

Volumn 14, Issue 11, 2008, Pages 1545-1556

  Finegold, Milton J ^a,b   Egler, Rachal A ^a,b   Goss, John A ^a   Guillerman, R Paul ^a,b   Karpen, Saul J ^a,b   Krishnamurthy, Rajesh ^a,b   O'Mahony, Ann ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; IRINOTECAN; VINCRISTINE;

ADD ON THERAPY; BONE SCINTISCANNING; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GENE MUTATION; HEPATOBLASTOMA; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PEDIATRIC SURGERY; PEDIATRICS; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

ADENOMA; ADOLESCENT; ANTINEOPLASTIC AGENTS; CARCINOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MEDICAL ONCOLOGY; PEDIATRICS; SARCOMA;

EID: 57849132675     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21654     Document Type: Review

References (78)

1. Avila LF, Luis AL, Hernandez F, Garcia Miguel P, Jara P, Andres AM, et al. Liver transplantation for malignant tumors in children. Eur J Pediatr Surg 2006;16:411-414.
2. Pham TH, Iqbal CW, Grams JM, Zarroug AE, Wall JC, Ishitani MB. Outcomes of primary liver cancer in children: an appraisal of experience. Pediatr Surg 2007;42:834-839.
3. Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 2006; 41:182-186.
4. Beaunoyer M, Vanatta JM, Ogihara M, Strichartz D, Dahl G, Berquist WE, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007;11:655-660.
5. Lopez-Terrada DL, Finegold MJ. Liver tumors. In: Walker AW, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, eds. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 5th ed. St. Louis, MO: C.V. Mosby; 2008:911-926.
6. Darbari A, Sabin KM, Shapiro CN, Schwartz KB. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003;38:560-566.
7. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.
8. Isaacs H Jr. Fetal and neonatal hepatic tumors. J Pediatr Surg 2007;42:1797-1803.
9. Perilongo G, Shafford E, Maibach R, Aronson D, Brugières L, Brock P, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2. Eur J Cancer 2004;40:411-421.
10. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol 2002;20:2789-2797.
11. Katzenstein, HM, Krailo MD, Malogolowkin MH, Ortega JA, Qi W, Douglass EC, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003;97: 2006-2012.
12. Czauderna P, Mackinlay G, Perilongo G, Brown J, Shafford E, Aronson D, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002;20:2798-2804.
13. Scheimann AO, Strautneiks SS, Knisely AS, Byrne JA, Thompson RJ, Finegold MJ. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr 2007;150:556-559.
14. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008;134:1203-1214.
15. Spunt SL, Lobe TE, Pappo AS. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 2000;35:309-316.
16. Webber EM, Morrison KB, Pritchard SL, Sorensen PH. Undifferentiated sarcoma of the liver: results of clinical management in one center. J Pediatr Surg 1999;34:1141-1144.
17. Bisogno G, Pilz T, Perilongo G, Ferrari A, Harms D, Ninfo V, et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer 2002;94:252-257.
18. Gunawardena SW, Trautwein LM, Finegold MJ, Ogden AK. Hepatic angiosarcoma in a child: successful treatment with surgery and adjuvant chemotherapy. Med Ped Oncol 1997;28:139-143.
19. Meyers RL. Tumors of the liver in children. Surg Oncol 2007;16:195-203.
20. Lee TC, Barshes NR, Agee EE, O'Mahony CA, Karpen SJ, Carter BA, et al. Resolution of medically resistant hypothyroidism after liver transplantation for hepatic hemangioendothelioma. J Pediatr Surg 2006;41:1783-1785.
21. Rodriguez JA, Becker NS, O'Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987-2005. J Gastrointest Surg 2008;12:110-116.
22. Chang MH. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B vaccination. Liver Int 2003;23:309-314.
23. Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review. Cancer 1998;82:1789-1796.
24. McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS. Maternal infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006;163:818-828.
25. Spector LG, Johnson KJ, Soler JT, Puumala SE. Perinatal risk factors for hepatoblastoma. Br J Cancer 2008;98: 1570-1573.
26. Reynolds M, Urayama KY, von Behren J, Feusner J. Birth characteristics and hepatoblastoma risk in young children. Cancer 2004;100:1070-1060.
27. Oue T, Kubota A, Okuyama H, Kawahara H, Nara K, Kawa K, Kitajama H. Hepatoblastoma in children of extremely low birth weight. J Pediatr Surg 2003;38:134-137.
28. Tan TY, Amor DJ. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 2006;42:486-490.
29. Aretz S, Koch A, Uhlhaas S, Friedl W, Propping P, von Schweinitz D, Pietsch T. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006;47:811-818.
30. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005; 147:263-266.
31. Attard TM, Tajouri T, Peterson KD, Tinley S, Thorson AG, Lynch HT. Familial adenomatous polyposis in children younger than age ten years: a multidisciplinary clinic experience. Dis Colon Rectum 2008;51:207-212.
32. Richter A, Glabhorn E, Schultz A, Schaefer JH, Burdelski M, Ganschow R. Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transpl 2005;9:805-808.
33. Taat F, Bosman DK, Aronson DC. Hepatoblastoma in a girl with biliary atresia. Pedriatr Blood Cancer 2004;43:603-605.
34. Shneider B, Suchy FJ, Emre S. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system. Liver Transpl 2006;12:40-45.
35. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
36. Aljabiri MR, Lodato F, Burroughs AK. Surveillance and diagnosis for hepatocellular carcinoma. Liver Transpl 2007;13:S2-S12.
37. Taouli B, Krinsky GA. Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Liver Transpl 2006;12(suppl 2):S1-S7.
38. Douglass EC, Green AA, Wrenn E, Champion J, Shipp M, Pratt CB. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 1985;13:187-190.
39. Mueller BU, Lopez-Terrada D, Finegold MJ. Tumors of the liver. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, PA: Lippincott-Williams & Wilkins; 2006:887-904.
40. McCarville MB, Kao SC. Imaging recommendations for malignant liver neoplasms in children. Pediatr Blood Cancer 2006;46:2-7.
41. Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007;37:123-132.
42. Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245-1252.
43. Emre S, McKenna GJ. Liver tumors in children. Pediatr Transpl 2004:8:632-638.
44. Malogolowkin MH, Katzenstein HM, Krailo MD, Rowland J, Haas J, Meyers R, et al. Complete surgical resection for children with pure fetal histology hepatoblastoma (PFH): a report of the Children's Oncology Group (COG) [abstract]. J Clin Oncol 2008;26(suppl):10049.
45. Fuchs J, Rydzynski J, Hecker H, Mildenberger H, Bürger D, Harms D, et al. The in.uence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma - a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg 2002;12:255-261.
46. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era: recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005;41:1031-1036.
47. Otte JB, de Ville GJ. The contribution of transplantation to the treatment of liver tumors in children. Semin Pediatr Surg 2005;14:233-238.
48. Stringer MD. The role of liver transplantation in the management of pediatric liver tumors. Ann R Coll Surg Engl 2007;89:12-21.
49. Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol 2008;26:2379-2383.
50. Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002;95:172-182.
51. Thomas BL, Krummel TM, Parker GA, Benator RM, Brewer WH, Cook DE, Salzberg AM. Use of interoperative ultrasound during hepatic resection in pediatric patients. J Pediatr Surg 1989;24:690-693.
52. Silberhumer GR, Steinringer R, Laengle R, Muehlbacher F, Zacherl J, Pokieser P. Intraoperative ultrasonography in patients who undergo liver resection on transplantation for hepatocellular carcinoma. Surg Technol Int 2004;12: 145-151.
53. Meyers RL, Katzenstein HM, Krailo M, McGahren ED III, Malogolowkin MH. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg 2007;42:2050-2056.
54. Perilongo G, Brown J, Shafford E, Brock P, DeCamargo B, Keeling JW, et al. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 2000;89: 1845-1853.
55. Katzenstein HM, Rigsby C, Shaw PH, Mitchell TL, Haut PR, Kletzel M. Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol 2002;24:751-755.
56. Malogolowkin MH, Stanley P, Steele DA, Ortega JA. Feasibility and toxicity of chemoembolization for children with liver tumors. J Clin Oncol 2000;18:1279-1284.
57. Arcement CM, Towbin RB, Meza MP, Gerber DA, Kaye RD, Mazariegos GV, et al. Intrahepatic chemoembolization in unresectable pediatric liver malignancies. Pediatr Radiol 2000;30:779-785.
58. Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Cardiovasc Intervent Radiol 2008. doi://10.1007/s00270-008-9373-x. Available at: http://www.springerlink.com.
59. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004;42:74-83.
60. D'Alessandro AM, Knechtle SJ, Chin LT, Fernandez LA, Yagci G, Leverson G, Kalayoglu M. Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. J Pediatr Transpl 2007:11:661-670.
61. Reyes JD, Carr B, Dvorchik, I, Kokoghos S, Jaffe R, Gerber D, et al. Liver transplantation and chemotherapy of hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000;135:795-804.
62. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
63. Otte J-B. Should the selection of children with hepatocellular carcinoma be based on Milan criteria? Pediatr Transpl 2008:12:1-3.
64. Weber M, Clavian P-A. Hepatocellular carcinoma and liver transplantation: entering the area after the Milan and University of California at San Francisco criteria? Liver Transpl 2008;14:911-914.
65. Killenberg PG, Clavien P-A. Medical Care of the Liver Transplant Patient. Oxford, England: Wiley-Blackwell; 2006:631.
66. Tiao G, Alonso MH, Ryckman FC. Liver transplantation in children. In: Suchy FJ, Sokol RJ, Balisteri WF, eds. Liver Disease in Children. 3rd ed. Cambridge, England: Cambridge University Press; 2006:975-993.
67. Busuttil RW, Klintmalm GB. Transplantation of the Liver. 2nd ed. New York, NY: Elsevier-Saunders; 2005:1520.
68. US Department of Health and Human Services. 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006. Available at: http://www.ustransplant.org/annual_reports/current. Accessed August 2008.
69. Wiesner RH, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. The Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
70. Barshes NR, Lee CT, Udell IW, O'Mahoney CA, Karpen SJ, Carter BA, Goss JA. The Pediatric End-Stage liver Disease (PELD) model as a predictor of survival benefit and post transplant survival in pediatric liver transplant recipients. Liver Transpl 2006;12:475-480.
71. Otte JB, deVille deGoyet J, Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 2005;9:557-565.
72. Jain A, Costa G, Marsh W, Fontes P, Devera M, Mazariegos G, et al. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int 2006;19:27-37.
73. Cheng YF, Chen CL, Huang TL, Chen TY, Chen YS, Wang CC, et al. 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl 2004;10:248-252.
74. Buell JF, Funaki B, Cronin DC, Yoshida A, Perlman MK, Lorenz J, et al. Long-term venous complications after full-size and segmental pediatric liver transplantation. Ann Surg 2002;236:658-656.
75. Heffron TG, Emond JC, Whitington PF, Thistlethwaite JR Jr, Stevens L, Piper J, et al. Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation 1992;53:391-395.
76. Suh MY, Wang K, Gutweiler JR, Misra MV, Krawczuk LE, Jenkins RL, et al. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma. J Pediatr Surg 2008;43:1148-1152.
77. Kerkar N, Emre, S. Issues unique to pediatric liver transplantation. Clin Liver Dis 2007;11:323-335.
78. Shepard RW, Turmelle Y, Nadler M. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transpl 2008;8:396-403.